La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
PainChek Gestion
Gestion contrôle des critères 3/4
PainChek's CEO is Philip Daffas, appointed in Sep 2016, has a tenure of 7.92 years. total yearly compensation is A$431.49K, comprised of 52.4% salary and 47.6% bonuses, including company stock and options. directly owns 1.55% of the company’s shares, worth A$835.26K. The average tenure of the management team and the board of directors is 3.4 years and 7.9 years respectively.
Informations clés
Philip Daffas
Directeur général
AU$431.5k
Rémunération totale
| Pourcentage du salaire du PDG | 52.4% |
| Durée du mandat du directeur général | 7.9yrs |
| Propriété du PDG | 1.5% |
| Durée moyenne d'occupation des postes de direction | 3.4yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 7.9yrs |
Mises à jour récentes de la gestion
Recent updates
We're Keeping An Eye On PainChek's (ASX:PCK) Cash Burn Rate
Jul 04
Is PainChek (ASX:PCK) In A Good Position To Invest In Growth?
Feb 08Will PainChek (ASX:PCK) Spend Its Cash Wisely?
Jul 05Companies Like PainChek (ASX:PCK) Can Afford To Invest In Growth
Jan 26We're Interested To See How PainChek (ASX:PCK) Uses Its Cash Hoard To Grow
Sep 07When Can We Expect A Profit From PainChek Limited (ASX:PCK)?
May 07PainChek (ASX:PCK) Is In A Strong Position To Grow Its Business
Mar 01Market Sentiment Around Loss-Making PainChek Limited (ASX:PCK)
Nov 20Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -AU$8m |
| Sep 30 2023 | n/a | n/a | -AU$8m |
| Jun 30 2023 | AU$431k | AU$226k | -AU$8m |
| Mar 31 2023 | n/a | n/a | -AU$7m |
| Dec 31 2022 | n/a | n/a | -AU$7m |
| Sep 30 2022 | n/a | n/a | -AU$6m |
| Jun 30 2022 | AU$411k | AU$227k | -AU$6m |
| Mar 31 2022 | n/a | n/a | -AU$6m |
| Dec 31 2021 | n/a | n/a | -AU$7m |
| Sep 30 2021 | n/a | n/a | -AU$6m |
| Jun 30 2021 | AU$470k | AU$232k | -AU$6m |
| Mar 31 2021 | n/a | n/a | -AU$5m |
| Dec 31 2020 | n/a | n/a | -AU$4m |
| Sep 30 2020 | n/a | n/a | -AU$8m |
| Jun 30 2020 | AU$4m | AU$319k | -AU$12m |
| Mar 31 2020 | n/a | n/a | -AU$12m |
| Dec 31 2019 | n/a | n/a | -AU$12m |
| Sep 30 2019 | n/a | n/a | -AU$8m |
| Jun 30 2019 | AU$378k | AU$205k | -AU$3m |
| Mar 31 2019 | n/a | n/a | -AU$3m |
| Dec 31 2018 | n/a | n/a | -AU$3m |
| Sep 30 2018 | n/a | n/a | -AU$4m |
| Jun 30 2018 | AU$402k | AU$205k | -AU$5m |
Rémunération vs marché: Philip's total compensation ($USD290.49K) is about average for companies of similar size in the Australian market ($USD299.11K).
Rémunération et revenus: Philip's compensation has increased whilst the company is unprofitable.
PDG
Philip Daffas
7.9yrs
Titularisation
AU$431,493
Compensation
Mr. Philip Daffas, BSc, Dip EENG, MBA, GAICD, has been Managing Director and Director at PainChek Limited since September 30, 2016 and serves as its Chief Executive Officer. Mr. Daffas served as Vice Presi...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| MD, CEO & Director | 7.9yrs | AU$431.49k | 1.55% A$ 835.3k | |
| Chief Financial Officer | 3.4yrs | AU$341.01k | 0.0030% A$ 1.6k | |
| Manager & Head of Operations | 3.4yrs | pas de données | pas de données | |
| Chief Technology Officer | 7.3yrs | pas de données | pas de données | |
| Chief Scientific Officer | no data | pas de données | pas de données | |
| Head of Business Development | no data | pas de données | pas de données | |
| Company Secretary | less than a year | pas de données | pas de données |
3.4yrs
Durée moyenne de l'emploi
Gestion expérimentée: PCK's management team is considered experienced (3.4 years average tenure).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| MD, CEO & Director | 7.9yrs | AU$431.49k | 1.55% A$ 835.3k | |
| Non-Executive Chairman of the Board | 7.9yrs | AU$143.90k | 1.04% A$ 561.4k | |
| Non-Executive Director | 9.9yrs | AU$71.95k | 0.87% A$ 470.4k | |
| Non-Executive Director | 7.9yrs | AU$71.95k | 0.59% A$ 320.9k | |
| Non-Executive Director | 2.4yrs | AU$71.95k | 0.13% A$ 71.6k | |
| Member of Clinical Advisory Board | 6.2yrs | pas de données | pas de données |
7.9yrs
Durée moyenne de l'emploi
79yo
Âge moyen
Conseil d'administration expérimenté: PCK's board of directors are considered experienced (7.9 years average tenure).